Company Filing History:
Years Active: 2017
Title: Sunil Kumar Bhola: Innovator in Cancer Treatment
Introduction
Sunil Kumar Bhola is a notable inventor based in Jammu, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for cancer and inflammatory disorders. His innovative work has the potential to impact the lives of many patients suffering from these conditions.
Latest Patents
Sunil Kumar Bhola holds a patent for a novel chromone alkaloid known as dysoline. This compound, identified by the formula 5,7-dihydroxy-6-(3-hydroxy-1-methylpiperidin-4-yl)-2-methyl-4H-chromen-4-one, has been found to be a potential inhibitor of cell growth and proliferation. Additionally, it inhibits the production of pro-inflammatory cytokines. The formulations derived from this compound can be utilized for the treatment of cancer and inflammation, showcasing its therapeutic potential.
Career Highlights
Sunil Kumar Bhola is affiliated with the Council of Scientific & Industrial Research, where he continues to engage in groundbreaking research. His work is characterized by a commitment to advancing scientific knowledge and developing practical applications for his discoveries.
Collaborations
He has collaborated with esteemed colleagues such as Ram Asrey Vishwakarma and Shreyans Kumar Jain, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Sunil Kumar Bhola's contributions to the field of medicinal chemistry, particularly through his patent on dysoline, highlight his role as an innovator in cancer treatment. His work exemplifies the importance of research in developing new therapies for critical health issues.